Acumen Pharmaceuticals(ABOS) - 2025 Q4 - Earnings Call Transcript

Acumen Pharmaceuticals (NasdaqGS:ABOS) Q4 2025 Earnings call March 26, 2026 08:00 AM ET Company ParticipantsAlex Braun - Head of Investor RelationsDaniel O'Connell - CEOEric Siemers - Chief Medical OfficerJason Zemansky - VP of Equity ResearchJim Doherty - President and Chief Development OfficerMatt Zuga - CFO and Chief Business OfficerConference Call ParticipantsDev Prasad - SVP and Biotech Equity Research AnalystMary Kate - AnalystTom Shrader - Equity Research AnalystNone - AnalystNone - AnalystOperatorLa ...